PHT Corporation to Convene Thought Leaders in Clinical Research and Patient Reported Outcomes (PRO) at Annual European PRO & ePRO Congress
Global ePRO innovator welcomes industry leaders in Clinical Research and the Biopharmaceutical industry May 17-19 in Annecy, France
PHT Corporation will welcome pacesetters in clinical research, health outcomes, patient reported outcomes, regulatory and eClinical function at Europe’s most informative and educational event on Patient Reported Outcomes (PRO) and Electronic Patient Reported Outcomes (ePRO ), the PRO and ePRO Congress in Annecy, France, May 17-19.
The PRO and ePRO Congress is one of the industry’s premier educational and networking forums for Clinical Operations, Health Outcomes, Data Management, eClinical Leadership, Regulatory Affairs, and Outsourcing professionals. Sponsors bringing members from across disciplines learn how their respective functional area benefits from PRO data and ePRO Systems.
PHT President and CEO Philip Lee said, “The Congress gives clinical trial professionals a unique opportunity to become PRO and ePRO experts. Attendees use the meeting to share ideas, best practices and success strategies about their implementations of PRO and ePRO. The end result is an increased knowledge base for all participants on how to run faster, more efficient clinical trials.”
The Congress will feature an address by Martin Duracinsky, MD, PhD from Assistance Publique - Hopitaux de Paris (AP-HP) on the development and validation of a global PRO Questionnaire for HIV patients; and, a presentation entitled “How ePRO Systems and Processes Determine Quality and Integrity of Meta-data for Investigations” by Dr. Beat Widler, International Head of Clinical Quality Assurance at F. Hoffman La-Roche.
Global industry leaders designed the agenda to give both new and expert participants a full understanding of how clinical, data management, regulatory, and outsourcing functional groups benefit and work with PRO data. Small group sessions will tutor to different levels of experience, so at the end of two days all levels of PRO users will have the tools and expertise to help their teams assess their PRO needs, expedite study set-up times, effectively implement PROs and ePRO systems, reduce time monitoring and analyzing data, and, lead future PRO initiatives.
The agenda features talks and panel discussions including case studies from biopharmaceutical sponsors, CROs, Clinical Investigators and PRO Developers. The Congress has 15 sessions run by leaders from 12 different organizations involved in clinical research trials and post-marketing studies. The detailed agenda is available at http://www.phtcorp.com/eugm2011/agenda.asp
Congress participants will see and discuss NetPRO ™, the first browser-based ePRO and eClinRO system that collects patient data via the Internet. PHT’s NetPRO enables researchers to access a larger global patient population while reducing the costs of large Phase 4 and extended post-market studies. Sponsors can use NetPRO to collect PRO data for regulatory submissions and label claims as well as for post-approval safety, observational, and registry studies.
Qualified companies and persons can register and learn more about the PRO and ePRO Congress at www.phtcorp.com/eugm2011 .
About PHT Corporation
PHT is the global innovator and experience leader in ePRO (electronic patient-reported outcome) Systems that reduce costs and improve data quality in clinical trials and post marketing studies. Since 1994, patient experiences captured by PHT's ePRO System have been used successfully in over 465 global trials by more than 100 biopharmaceutical companies, resulting in at least 19 regulatory submissions and 16 approvals to date. The benefits ePRO systems provide to sponsors include reliable patient compliance; reduced data variance of PRO endpoints for smaller, more conclusive trials; increased patient safety monitoring; and, decreased timelines from trial end to data analysis. Sponsors using PHT’s ePRO System consistently report significant R&D cost savings and better scientific outcomes vs. paper. For more information, review the educational content and interactive PHT ePRO System demonstrations at phtcorp.com.
PHT, LogPad, NetPRO and SitePad are registered trademarks of PHT Corporation.
Contact:
PHT Corporation
Brenda Nashawaty, 617-688-3253
brenda@nashawaty.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release
BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee
Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte
You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release
More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release
Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom